Aprea Therapeutics, Inc. Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aprea Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aprea Therapeutics, Inc. for October 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 15.00 | 333,333 | 4,999,995 | 333,333 | 0 to 333.3 K |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) |
| Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) |
| Oct 08 2019 | APRE | Aprea Therapeutics ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,164,674 | 0 | 0 | |
| Oct 08 2019 | APRE | Aprea Therapeutics ... | Redmile Group, LLC | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 2,268,718 | 1.9 M to 2.3 M (+21.41 %) |
| Oct 08 2019 | APRE | Aprea Therapeutics ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 1,868,718 | 0 | 1,868,718 | 0 to 1.9 M |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 427,496 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 427,496 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,661,382 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,661,382 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Buy | P | 15.00 | 266,667 | 4,000,005 | 2,366,104 | 2.1 M to 2.4 M (+12.70 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Buy | P | 15.00 | 266,667 | 4,000,005 | 2,366,104 | 2.1 M to 2.4 M (+12.70 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Buy | C | 0.00 | 427,496 | 0 | 2,099,437 | 1.7 M to 2.1 M (+25.57 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Buy | C | 0.00 | 427,496 | 0 | 2,099,437 | 1.7 M to 2.1 M (+25.57 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Buy | C | 0.00 | 1,661,382 | 0 | 1,671,941 | 10.6 K to 1.7 M (+15,734.27 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HealthCap VII, L.P. | 10% Owner | Buy | C | 0.00 | 1,661,382 | 0 | 1,671,941 | 10.6 K to 1.7 M (+15,734.27 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Option Exercise | C | 0.00 | 512,995 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Option Exercise | C | 0.00 | 512,995 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Option Exercise | C | 0.00 | 1,993,658 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Option Exercise | C | 0.00 | 1,993,658 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Buy | P | 15.00 | 333,333 | 4,999,995 | 333,333 | 0 to 333.3 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Buy | P | 15.00 | 333,333 | 4,999,995 | 333,333 | 0 to 333.3 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Buy | C | 0.00 | 512,995 | 0 | 2,519,323 | 2 M to 2.5 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Buy | C | 0.00 | 512,995 | 0 | 2,519,323 | 2 M to 2.5 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Buy | C | 0.00 | 1,993,658 | 0 | 2,006,328 | 12.7 K to 2 M (+15,735.26 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant Vantage I, L.P. | Buy | C | 0.00 | 1,993,658 | 0 | 2,006,328 | 12.7 K to 2 M (+15,735.26 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Option Exercise | C | 0.00 | 512,995 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Option Exercise | C | 0.00 | 512,995 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Option Exercise | C | 0.00 | 1,993,658 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Option Exercise | C | 0.00 | 1,993,658 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Buy | P | 15.00 | 333,333 | 4,999,995 | 333,333 | 0 to 333.3 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Buy | P | 15.00 | 333,333 | 4,999,995 | 333,333 | 0 to 333.3 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Buy | C | 0.00 | 512,995 | 0 | 2,519,323 | 2 M to 2.5 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Buy | C | 0.00 | 512,995 | 0 | 2,519,323 | 2 M to 2.5 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Buy | C | 0.00 | 1,993,658 | 0 | 2,006,328 | 12.7 K to 2 M (+15,735.26 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Versant V Luxco S.a r.l. | Buy | C | 0.00 | 1,993,658 | 0 | 2,006,328 | 12.7 K to 2 M (+15,735.26 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Option Exercise | C | 0.00 | 427,496 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Option Exercise | C | 0.00 | 427,496 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Option Exercise | C | 0.00 | 1,661,382 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Option Exercise | C | 0.00 | 1,661,382 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Buy | P | 15.00 | 266,667 | 4,000,005 | 2,366,104 | 2.1 M to 2.4 M (+12.70 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Buy | P | 15.00 | 266,667 | 4,000,005 | 2,366,104 | 2.1 M to 2.4 M (+12.70 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Buy | C | 0.00 | 427,496 | 0 | 2,099,437 | 1.7 M to 2.1 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Buy | C | 0.00 | 427,496 | 0 | 2,099,437 | 1.7 M to 2.1 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Buy | C | 0.00 | 1,661,382 | 0 | 1,671,941 | 10.6 K to 1.7 M (+15,734.27 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Christenson Johan | Buy | C | 0.00 | 1,661,382 | 0 | 1,671,941 | 10.6 K to 1.7 M (+15,734.27 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Seizinger Bernd R. | Option Exercise | M | 0.07 | 263,970 | 18,478 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Seizinger Bernd R. | Option Exercise | M | 0.07 | 263,970 | 18,478 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Seizinger Bernd R. | Buy | M | 0.07 | 263,970 | 18,478 | 263,970 | 0 to 264 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Seizinger Bernd R. | Buy | M | 0.07 | 263,970 | 18,478 | 263,970 | 0 to 264 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Option Exercise | C | 0.00 | 430,467 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Option Exercise | C | 0.00 | 430,467 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Option Exercise | C | 0.00 | 590,445 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Option Exercise | C | 0.00 | 590,445 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Option Exercise | C | 0.00 | 579,647 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Option Exercise | C | 0.00 | 579,647 | 0 | 0 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Buy | C | 0.00 | 1,600,559 | 0 | 2,444,837 | 844.3 K to 2.4 M (+189.58 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | KDev Investments AB | 10% Owner | Buy | C | 0.00 | 1,600,559 | 0 | 2,444,837 | 844.3 K to 2.4 M (+189.58 %) |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Magni Guido | Buy | P | 15.00 | 6,500 | 97,500 | 6,500 | 0 to 6.5 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Magni Guido | Buy | P | 15.00 | 6,500 | 97,500 | 6,500 | 0 to 6.5 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HENNEMAN JOHN B III | Option Exercise | A | 15.00 | 18,407 | 276,105 | 18,407 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HENNEMAN JOHN B III | Option Exercise | A | 15.00 | 18,407 | 276,105 | 18,407 | ||
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HENNEMAN JOHN B III | Buy | P | 15.00 | 5,000 | 75,000 | 5,000 | 0 to 5 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | HENNEMAN JOHN B III | Buy | P | 15.00 | 5,000 | 75,000 | 5,000 | 0 to 5 K | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Korbel Gregory Alan | VP of Business Dev' ... | Option Exercise | A | 15.00 | 64,322 | 964,830 | 64,322 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Korbel Gregory Alan | VP of Business Dev' ... | Buy | P | 15.00 | 500 | 7,500 | 500 | 0 to 500 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Korbel Gregory Alan | VP of Business Dev' ... | Option Exercise | A | 15.00 | 64,322 | 964,830 | 64,322 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Korbel Gregory Alan | VP of Business Dev' ... | Buy | P | 15.00 | 500 | 7,500 | 500 | 0 to 500 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Abrahmsen Lars B. | SVP, Chief Scientif ... | Option Exercise | A | 15.00 | 77,630 | 1,164,450 | 77,630 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Abrahmsen Lars B. | SVP, Chief Scientif ... | Option Exercise | A | 15.00 | 77,630 | 1,164,450 | 77,630 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Option Exercise | A | 15.00 | 77,630 | 1,164,450 | 77,630 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Option Exercise | A | 15.00 | 77,630 | 1,164,450 | 77,630 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 150,824 | 2,262,360 | 150,824 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 150,824 | 2,262,360 | 150,824 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Buy | P | 15.00 | 2,500 | 37,500 | 2,500 | 0 to 2.5 K |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Buy | P | 15.00 | 2,500 | 37,500 | 2,500 | 0 to 2.5 K |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Option Exercise | A | 15.00 | 306,085 | 4,591,275 | 306,085 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Option Exercise | A | 15.00 | 306,085 | 4,591,275 | 306,085 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 5,000 | 75,000 | 5,000 | 0 to 5 K |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 5,000 | 75,000 | 5,000 | 0 to 5 K |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |